Georgina Long wins award for Outstanding Cancer Research
22 August 2014
Dr Georgina Long, Associate Professor of Melanoma Biology and Transitional Research, and Medical Oncologist at Melanoma Institute Australia, was awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research. This is the second year in a row that she has received an award from Cancer Institute NSW.
Georgina's area of focus is Phase I, II, and III clinical trials in adjuvant and metastatic melanoma and, along with her colleagues, has spear-headed the investigation of BRAF inhibitor activity in the brain. She is the chief investigator on the National Health and Medical Research Council funded research into molecular biology of melanoma, with a particular focus on clinical and biomarker correlates of systematic therapy sensitivity and resistance.
The Wildfire Award is awarded to an individual, or research team, for a highly cited publication that is expected to significantly influence cancer control or further research.
Little Madi misses her Dad. But she is determined to honour his memory and support life-saving melanoma research.
Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma
Melanoma Institute Australia has teamed up with the Toyota Country Music Festival 2018 in Tamworth!
MIA's dermatologist shares her knowledge with GPs on debunking myths and controversies on sunscreen.
Shannan Ponton thought he was invincible – he wasn’t. But his melanoma battle ended up saving more than his own life.
Researchers have demonstrated that immunotherapy is highly effective in treating a rare form of melanoma – a result that is surprising due to the nature of the tumour.
Innovation is helping to prevent melanoma developing in the first place.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.